Skip to main content
Premium Trial:

Request an Annual Quote

Circular Genomics: Paul Sargeant

Circular Genomics, an Albuquerque, New Mexico-based company developing precision medicine and diagnostic tools based on circular RNA, has appointed Paul Sargeant as CEO. Sargeant has more than 25 years of life science industry leadership and management experience including clinical diagnostics assay, instrumentation platform, and software development; regulatory approvals; and commercial launch experience, according to Circular. Most recently, Sargeant was CEO of Rebus Biosystems, an Illumina Ventures-backed spatial biology company. He holds a PhD in physiology from the University of Cambridge.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.